The risk of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a UK population-based outpatient cohort study

被引:125
作者
Choi, Hyon K. [1 ,2 ,3 ,4 ]
Rho, Young-Hee [2 ]
Zhu, Yanyan [2 ]
Cea-Soriano, Lucia [2 ]
Avina-Zubieta, Juan Antonio [3 ,4 ]
Zhang, Yuqing [2 ]
机构
[1] Boston Univ, Sch Med, Rheumatol Sect, Boston, MA 02118 USA
[2] Boston Univ, Sch Med, Clin Epidemiol Unit, Boston, MA 02118 USA
[3] Arthrit Res Ctr Canada, Vancouver, BC, Canada
[4] Univ British Columbia, Div Rheumatol, Vancouver, BC V5Z 1M9, Canada
关键词
IMPROVEMENT NETWORK THIN; VENOUS THROMBOEMBOLISM; CAROTID ATHEROSCLEROSIS; PSORIATIC-ARTHRITIS; TERM MORTALITY; VALIDATION; DIAGNOSES; DISORDERS; INFECTION; DISEASE;
D O I
10.1136/annrheumdis-2012-201669
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Background Recent hospital-based studies have suggested a sixfold increased risk of pulmonary embolism (PE) in rheumatoid arthritis (RA) in the year following admission. We evaluated the risk of PE and deep vein thrombosis (DVT) and associated time trend among RA patients (84.5% without a history of hospitalisation during the past year) derived from the general population. Methods We conducted a cohort study using an electronic medical records database representative of the UK general population, collected from 1986 to 2010. Primary definitions of the RA cohort (exposure) and PE/DVT outcomes required physician diagnoses followed by corresponding treatments. We estimated relative risks (RRs) of PE and DVT compared with a matched non-RA comparison cohort, adjusting for age, sex, smoking, body mass index, comorbidities and hospitalisations. Results Among 9589 individuals with RA (69% female, mean age of 58 years), 82 developed PE and 110 developed DVT (incidence rates, 1.5 and 2.1 per 1000 person-years). Compared with non-RA individuals (N=95 776), the age-, sex-and entry-time-matched RRs were 2.23 (95% CI 1.75 to 2.86) for PE and 2.20 (CI 1.78 to 2.71) for DVT. Adjusting for other covariates, the corresponding RRs were 2.16 (CI 1.68 to 2.79) and 2.16 (CI 1.74 to 2.69). The time-specific RRs for PE were 3.27, 1.88 and 2.35 for follow-up times of <1 year, 1-4.9 years, and >= 5 years, and corresponding RRs for DVT were 3.16, 1.82 and 2.32. Conclusions This population-based study indicates an increased risk of PE and DVT in RA, supporting increased monitoring of venous-thromboembolic complications and risk factors in RA, regardless of hospitalisation.
引用
收藏
页码:1182 / 1187
页数:6
相关论文
共 52 条
[1]
[Anonymous], 2000, SURV METHODOL
[2]
Risk of Cardiovascular Mortality in Patients With Rheumatoid Arthritis: A Meta-Analysis of Observational Studies [J].
Avina-Zubieta, J. Antonio ;
Choi, Hyon K. ;
Sadatsafavi, Mohsen ;
Etminan, Mahyar ;
Esdaile, John M. ;
Lacaille, Diane .
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2008, 59 (12) :1690-1697
[3]
Noncardiac vascular disease in rheumatoid arthritis: Increase in venous thromboembolic events? [J].
Bacani, A. Kirstin ;
Gabriel, Sherine E. ;
Crowson, Cynthia S. ;
Heit, John A. ;
Matteson, Eric L. .
ARTHRITIS AND RHEUMATISM, 2012, 64 (01) :53-61
[4]
Bhagat K, 1996, CARDIOVASC RES, V32, P822
[5]
Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo [J].
Bhagat, K ;
Vallance, P .
CIRCULATION, 1997, 96 (09) :3042-3047
[6]
HOW DOES THE HEALTH IMPROVEMENT NETWORK (THIN) DATA ON PREVALENCE OF CHRONIC DISEASES COMPARE WITH NATIONAL FIGURES? [J].
Blak, B. T. ;
Thompson, M. .
VALUE IN HEALTH, 2009, 12 (07) :A253-A253
[7]
Borensztajn KS, 2011, CURR PHARM DESIGN, V17, P9
[8]
Methotrexate and mortality in patients with rheumatoid arthritis:: a prospective study [J].
Choi, HK ;
Hernán, MA ;
Seeger, JD ;
Robins, JM ;
Wolfe, F .
LANCET, 2002, 359 (9313) :1173-1177
[9]
Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study [J].
Choi, Hyon K. ;
Soriano, Lucia Cea ;
Zhang, Yuqing ;
Garcia Rodriguez, Luis A. .
BRITISH MEDICAL JOURNAL, 2012, 344
[10]
Venous thrombotic events are not increased in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register [J].
Davies, Rebecca ;
Galloway, James B. ;
Watson, Kath D. ;
Lunt, Mark ;
Symmons, Deborah P. M. ;
Hyrich, Kimme L. .
ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (10) :1831-1834